Randomised, Double Blind, Parallel Group Study to Assess the Bronchodilative and Bronchoprotective Properties of SERETIDE DISKUS® Inhaler 50/100 mcg Twice Daily vs FLIXOTIDE® Inhaler 200 mcg Twice Daily
Phase of Trial: Phase IV
Latest Information Update: 26 Sep 2016
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 15 Oct 2008 Actual start date changed from Dec 2003 to Dec 2002 as reported by ClinicalTrials.gov.
- 14 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Oct 2006 New trial record.